Navigation Links
Updated Phase 1 Data for Exelixis' XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
Date:10/23/2007

-Encouraging signs of anti-tumor activity observed in patients with

medullary thyroid cancer-

SAN FRANCISCO, Oct. 23 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today reported encouraging data from an ongoing phase 1 trial of XL184, a potent inhibitor of MET, RET, and VEGFR kinases, in patients with advanced solid tumors or lymphoma. Anti-tumor activity has been observed in a variety of cancers at doses that are not associated with significant toxicity. Consistent with the anti-VEGFR activity of XL184, preliminary pharmacodynamic analyses show reductions in several biomarkers of angiogenesis. Data were presented today in a poster session (Abstract #A152) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held October 22-26, 2007 in San Francisco.

There were 33 patients available for safety, pharmacokinetic, and tumor response analyses as of the June 22, 2007 cutoff; further data were also provided for six additional patients after the cutoff. Of seven patients with medullary thyroid cancer (MTC), three have had partial responses (2 confirmed and 1 unconfirmed). Six of the seven patients had tumor shrinkage and one had non-measurable disease. All seven assessable patients with MTC experienced a rapid decrease in plasma levels of calcitonin, a marker frequently elevated in medullary thyroid cancer, and six of the seven patients had a decrease in the tumor marker carcinoembryonic antigen (CEA). All seven MTC patients are still on study. In addition, one patient with a neuroendocrine tumor has an unconfirmed partial response. In total, 15 patients with various solid malignancies or lymphoma have had stable disease
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
3. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
4. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
5. Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
8. Media Advisory: ACC Updated Schedule
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
(Date:8/29/2014)... -- , Industry professionals and media ... taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of #CPhIChat ... its kind global industry-wide Tweetchat for pharma professionals ... to stimulate conversations on key industry issues and ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
(Date:9/1/2014)... 01, 2014 Top10BestSEOHosting.com has recently ... web host suppliers carefully, Top10BestSEOHosting.com is here to ... best web hosting suppliers in 2014. , JustHost ... with a top-of-the-line shared hosting plan. The company’s ... platform that is affordable, accessible and powerful enough ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Pastor Thompson is ... Specialist at Eagle Village. He is a licensed minister through ... over the past twenty years in New Mexico, Colorado and ... years of marriage this year. He also has two ... a B.S. in Pastoral Ministry from Nazarene Bible College, in ...
(Date:8/31/2014)... 2014 An analysis of 32 studies ... revealed a link between lower levels of Vitamin D ... the August 2014 issue of American Journal ... form of Vitamin D found in blood. , ... D lower than 9 nanograms/milliliter (ng/mL) were twice as ...
(Date:8/31/2014)... GoDaddy, IX Web Hosting and Bluehost are ... Server) hosting, which is the method of partitioning ... of which has the appearance and capabilities of ... recently compared many professional web hosting suppliers and ... VPS hosting suppliers in the global market. , ...
(Date:8/31/2014)... of hard work, Delta has now become one of the ... has updated its wheel loader assortment with a ... are guaranteed to be great. Additionally, they are offered at ... that all items in Delta’s used cat 966 loader ... is making full efforts to help worldwide customers to get ...
Breaking Medicine News(10 mins):Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 2Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 3Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 4Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2
... Professor Lewis Glinert and Jon Schommer, the associate head ... at the University of Minnesota, have examined the corporate ... found a startling lack of consistency in an industry ... Drug Administration (FDA). "Communicating via a website ...
... ... sunscreen provides broad spectrum protection for skin from the sun,s harmful rays. , ... (PRWEB) June 30, 2010 ... is introducing a non-chemical natural sunscreen armed with unparalleled protection, barely-there feel, ...
... complete cascade of signals within breast tumour cells activated by ... the activity of the oncogene p21Ras, changes in protein signaling ... damage. The study was carried out in an experimental model ... cell lines. Breast cancer is the most common ...
... ... Channel® continue to beat expectations , , ... (PRWEB) June 30, 2010 -- Healing HealthCare Systems (HHS) based ... growth and consistent demand for its industry-leading product, The C.A.R.E. Channel , evidence-based relaxation ...
... , ... face an increasingly complex landscape of breach notification requirements for protected health information (PHI). ... pressing entities to notify within 60 days of discovery. Kroll’s expanded data breach solutions ... continuum. , ...
... ... and language competency. , ... UK (PRWeb UK) June 30, 2010 -- HCL plc, one of the UK’s leading health ... a review of the processes which overseas doctors must undergo before they can ...
Cached Medicine News:Health News:Linguistics professor examines manufacturers' prescription drug websites 2Health News:As Summer Heats Up, Glacier Creme Debuts the Ultimate in Natural Sunscreen: 'Naked Protection' with Zinc Oxide 2Health News:A key mechanism links virgin olive oil to protection against breast cancer 2Health News:High Customer Retention and Continual Product Demand Drive Steady Growth for Innovative Healthcare Company 2Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 2Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 3Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 4Health News:HCL Supports Reform of Language Testing for International Doctors 2Health News:HCL Supports Reform of Language Testing for International Doctors 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: